Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

Abstract

Early-stage lung adenocarcinoma is typically treated by surgical resection of the tumor. While in the majority of cases surgery can lead to cure, approximately 30% of patients progress. Despite intense efforts to map the genetic landscape of early-stage lung tumors, there has been limited success in discovering accurate biomarkers that can predict clinical outcomes. Meanwhile, the role of the tumor-adjacent tissue in cancer progression has been largely ignored. To test whether tumor-adjacent tissue can be informative of progression-free survival and to probe the underlying molecular pathways involved, we designed a multi-omic study in both tumor and matched tumor-adjacent histologically normal lung tissue from the same patient. Our study includes 143 treatment naive stage I cases with long-term patient follow-up and is, to our knowledge, the largest such study with the longest follow-up. We performed a comprehensive histologic characterization of all tumors, mapped the mutational landscape and probed the transcriptome of both tumor and adjacent normal tissue. We evaluated the predictive power of each data modality and showed that the transcriptome of tumor-adjacent histologically normal lung tissue is the only reliable predictor of clinical outcome. Unbiased discovery of co-expressed gene modules revealed that inflammatory pathways are upregulated in the tumor-adjacent tissue of patients at high risk for disease progression. Furthermore, single-cell transcriptome analysis in the tumor-adjacent lung demonstrated that progression-associated inflammatory signatures were broadly expressed by both immune and non-immune cells including mesothelial cells, alveolar type 2 cells and fibroblasts, CD1 dendritic cells and MAST cells. Collectively, our studies suggest that molecular profiling of tumor-adjacent tissue can identify patients that are at high risk for disease progression.

Integrated bioinformatics analysis reveals the bidirectional effects of TSPAN6 for cisplatin resistance in lung cancer

“…2.3 | Single-nuclei RNA sequencing (snRNA-seq) analysis GSE229253 (Dolgalev et al, 2023) validated hub gene expression, excluding genes with fewer than 200 detected genes. Details are in the Appendix S1.…”

The Grading System for Lung Adenocarcinoma: Brief Review of its Prognostic Performance and Future Directions

“…Studies evaluating gene and protein expression in adenocarcinoma have shown no significant association with specific histologic patterns, 41,42 that is, there is no gene/ protein signature for individual histologic patterns. It has been shown however that histologic patterns are associated with distance from stem cell differentiation: lepidic pattern is closer to differentiated pulmonary epithelium, whereas highgrade histologic patterns are closer to stem cells, 43 thus confirming an association of patterns with differentiation.…”

Role of Biochemical Markers in Early Detection and Prognostication of Cancer Pathology

“…The discoveries add to a more profound comprehension of the growth microenvironment and its effect on clinical results. Elena-Georgiana Dobre et al [ 24] give an exhaustive outline of imaging methods in skin malignant growth pathobiology. The review accentuates the capability of cutting edge imaging advancements for further developed conclusion and observation in clinical companions.…”